| Literature DB >> 8438092 |
J F Spiegel1, M A Spear, J M Brown.
Abstract
We have investigated the feasibility of administration of an effective dose of the hypoxic cytotoxin, SR 4233, Monday-Friday daily for 6 weeks. From a thorough hematological, histopathological and clinical chemistry evaluation throughout the course and during a 3-week recovery period, we conclude that daily administration of a radiopotentiating dose of SR 4233 in mice is well tolerated and that bone marrow suppression is likely to be the dose-limiting toxicity.Entities:
Mesh:
Substances:
Year: 1993 PMID: 8438092 DOI: 10.1016/0167-8140(93)90031-3
Source DB: PubMed Journal: Radiother Oncol ISSN: 0167-8140 Impact factor: 6.280